Elutia ELUT 深 沪
已收盘 08-21 16:00:00 美东时间
0.9509
+0.049
+5.44%
华盛通- 最 高0.9509
- 今 开0.93
- 成交量 8215股
- 最 低 0.92
- 昨 收 0.9018
- 总市值 4.21万
- 52周最高 2.38
- 市盈率 静 --
- 换手率 0.02%
- 52周最低 0.50
- 委 比 -80.97%
- 总股本 4.43万
- 历史最高 18.20
- 量 比 0.13
- 振 幅 3.43%
- 历史最低 0.50
- 每 手 1
- 风险率 0.32%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Elutia Completes SimpliDerm® Sale on Schedule, Adds $8 Million in Cash to Fund NXT-41x Through Full Commercial Launch
Elutia Inc. has completed the sale of its SimpliDerm® business to Cellution Biologics Inc. for up to $11 million, with $8 million paid at closing and up to $3 million in milestone payments over the next 18 months. The transaction allows Elutia to focus on developing and commercializing NXT-41x, an antibiotic-eluting biomatrix designed to prevent post-operative infections in the $1.5 billion U.S. plastic and reconstructive surgery market. FDA clea...
08-18 12:00
Elutia Q2 EPS $(0.17) Misses $(0.15) Estimate, Sales $2.427M Miss $2.900M Estimate
Elutia (NASDAQ:ELUT) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.15) by 13.33 percent. This is a 34.62 percent increase over losses of $(0.26) per share from the same period last year. The company reported quarterly sales of $2.427 million which ...
08-14 04:11
Elutia Sheds Legacy Business to Chase $1.5 Billion Market Opportunity
Biomatrix technology innovator Elutia Inc. (NASDAQ:ELUT) on Friday agreed to divest its SimpliDerm human acellular dermal matrix operations. The buyer, Cellution Biologics Inc., will acquire the asset in a transaction that could be valued at a maximum of $11 million. This strategic sale allows the m...
07-18 00:07
Elutia Reports Q1 2026 Results: Full Earnings Call Transcript
Elutia (NASDAQ:ELUT) released first-quarter financial results and hosted an ear...
05-15 05:55
Elutia Q1 EPS $(0.17) Misses $(0.15) Estimate, Sales $3.114M Beat $3.000M Estimate
Elutia (NASDAQ:ELUT) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.15) by 13.33 percent. This is a 19.05 percent increase over losses of $(0.21) per share from the same
05-15 04:14
Earnings Scheduled For May 14, 2026
Companies Reporting Before The Bell • Urban One (NASDAQ:UONEK) is expected to r...
05-14 19:11
Elutia Q4 EPS $(0.14), Inline, Sales $3.271M Miss $3.300M Estimate
Elutia (NASDAQ:ELUT) reported quarterly losses of $(0.14) per share which met the analyst consensus estimate. This is a 47.31 percent increase over losses of $(0.26) per share from the same period last year. The company
03-12 04:09
Earnings Scheduled For March 11, 2026
Companies Reporting Before The Bell • Sprinklr (NYSE:CXM) is estimated to repor...
03-11 19:11
Exploring Elutia's Earnings Expectations
Elutia (NASDAQ:ELUT) is gearing up to announce its quarterly earnings on Wednes...
03-11 02:01
Elutia Regains Nasdaq Compliance
Elutia Inc. (Nasdaq: ELUT) ("Elutia" or the "Company"), a pioneer in drug-eluting biomatrix technologies, today announced that it has received notice from Nasdaq that Elutia has regained compliance with the minimum bid
03-04 21:07
